Tscan Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Tscan Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Tscan Therapeutics Inc
Rating: 1.67333325
Author: Trendlyne DVM scores

about

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...

1.82 -0.07 (-3.70%)

75.54% Fall from 52W High

177.7K

XNAS Volume

XNAS 18 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

19.3 / 100

Technically Neutral

47.6 / 100

1Yr Price target upside is 395%

7 analysts

Tscan Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tscan Therapeutics Inc Live Share Price Today, Share Analysis and Chart

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...

75.54% Fall from 52W High

SWOT Analysis

Tscan Therapeutics Inc Live Price Chart